Diality Welcomes Widely Published, Renowned Kidney Care Expert and Educator as Newest Board of Directors Member - Dr. Allen R. Nissenson, FACP, FASN, FNKF
IRVINE, Calif., Aug. 30, 2021 /PRNewswire/ -- Diality Inc. officially announced the addition of Dr. Nissenson to its board of directors. A widely acknowledged expert in kidney disease, Dr. Nissenson is Emeritus Professor of Medicine at the David Geffen School of Medicine at UCLA where he also served as both associate dean and the director of the dialysis program. He was Chief Medical Officer for DaVita Kidney Care for over 11 years and now serves as emeritus chief medical officer... Read the full press release here.
Diality Poised to Revolutionize Dialysis Treatment – In Development of Versatile Home Dialysis System; Welcomes Industry Veteran Dan Guthrie as Chief Business Officer
IRVINE, Calif., July 6, 2021 /PRNewswire/ -– Medical device startup Diality announced Dan Guthrie would become the newest member of its executive team, serving as Chief Business Officer effective July 1... Read the full press release here.
Diality Closes $12.5 Million of Series B Financing to Support Ongoing Development of a Portable System for Acute and Chronic Hemodialysis
IRVINE, Calif., Oct. 20, 2020 /PRNewswire/ -- Diality Inc, a medical device company that is developing a versatile hemodialysis system to address the unmet technology needs of the evolving dialysis industry, announced the close of a $12.5 million Series B investment round... Read the full press release here.
ASN Kidney Week 2021, San Diego, California
Visit Diality during Kidney Week 2021, Nov. 4-7. Visit the ASN Kidney Week 2021 web site.